Envestnet Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,971
| Closed | -$406K | – | 4088 |
|
|
2021
Q4 | $406K | Sell |
7,971
-890
| -10% | -$45.3K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $494K | Buy |
8,861
+462
| +6% | +$25.8K | ﹤0.01% | 2968 |
|
|
2021
Q2 | $359K | Sell |
8,399
-1,415
| -14% | -$60.5K | ﹤0.01% | 3179 |
|
|
2021
Q1 | $410K | Buy |
9,814
+142
| +1% | +$5.93K | ﹤0.01% | 2959 |
|
|
2020
Q4 | $450K | Sell |
9,672
-761
| -7% | -$35.4K | ﹤0.01% | 2711 |
|
|
2020
Q3 | $443K | Sell |
10,433
-228
| -2% | -$9.68K | ﹤0.01% | 2528 |
|
|
2020
Q2 | $512K | Sell |
10,661
-266
| -2% | -$12.8K | ﹤0.01% | 2412 |
|
|
2020
Q1 | $503K | Buy |
10,927
+469
| +4% | +$21.6K | ﹤0.01% | 2228 |
|
|
2019
Q4 | $628K | Sell |
10,458
-669
| -6% | -$40.2K | ﹤0.01% | 2314 |
|
|
2019
Q3 | $629K | Buy |
11,127
+1,300
| +13% | +$73.5K | ﹤0.01% | 2234 |
|
|
2019
Q2 | $547K | Buy |
9,827
+2,016
| +26% | +$112K | ﹤0.01% | 2347 |
|
|
2019
Q1 | $394K | Buy |
7,811
+1,431
| +22% | +$72.2K | ﹤0.01% | 2480 |
|
|
2018
Q4 | $257K | Buy |
+6,380
| New | +$257K | ﹤0.01% | 2519 |
|